Exam Preview
Exam Preview
A Primer on Non-Medical Prescription Opioid Misuse: Prevalence, Trends, and Clinical Implications
Please note: exam questions are subject to change.
1. Which of the following opioids is NOT prescribed?
|
||
2. Which of the following is available as a nasal spray and can be a life-saving drug?
|
||
3. Nonopioid therapy is:
|
||
4. Non-pharmacologic therapy includes all of the following EXCEPT:
|
||
5. What is the street name for Xylazine?
|
||
6. Methadone can be beneficial in:
|
||
7. Naltrexone is __________________.
|
||
8. An estimated ____ million people live with chronic pain.
|
||
9. Drug misuse includes:
|
||
10. What percent of drug overdose deaths in the United States are due to opioids?
|
||
11. Which of the following is a risk factor for opioid misuse?
|
||
12. According to Dr. Gomes and colleagues, opioid toxicity is responsible for _____% of all deaths among those aged 30 to 39 years.
|
||
13. When thinking about opioid toxicity, a particular focus should be devoted to which subgroup?
|
||
14. The pandemic may have contributed to increased rates of substance use due to ______.
|
||
15. According to Marsack-Topolewski and Chan (2024), adolescents with disabilities who engaged in non-medical prescription opioid misuse had over ____ times the likelihood for serious thoughts of suicide.
|